Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
    1.
    发明公开
    Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs 审中-公开
    使用PCV2免疫原性组合物减轻猪的临床症状

    公开(公告)号:EP2374476A1

    公开(公告)日:2011-10-12

    申请号:EP11164856.4

    申请日:2006-12-28

    IPC分类号: A61K39/12

    摘要: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 2 (PCV2) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV2 infection. Preferably, they include lymphadenopathy, lymphoid depletion and/or multinucleated/giant histiocytes. Moreover, the clinical symptoms include lymphadenopathy in combination with one or a multiple of the following symptoms in pigs: (1) interstitial pneumonia with interlobular edema, (2) cutaneous pallor or icterus, (3) mottled atrophic livers, (4) gastric ulcers, (5) nephritis and (6) reproductive disorders, e.g. abortion, stillbirths, mummies, etc. Furthermore the clinical symptoms include Pia like lesions, normally known to be associated with Lawsonia intracellularis infections.

    摘要翻译: 本发明涉及包含猪圆环病毒2型(PCV2)抗原的免疫原性组合物用于治疗几种临床表现(疾病)的用途。 优选地,临床表现与PCV2感染有关。 优选地,它们包括淋巴结病,淋巴耗竭和/或多核/巨组织细胞。 此外,临床症状包括淋巴结病和猪中的一种或多种以下症状:(1)伴有小叶间水肿的间质性肺炎,(2)皮肤苍白或黄疸,(3)斑驳萎缩肝,(4)胃溃疡 ,(5)肾炎和(6)生殖障碍,例如 流产,死胎,木乃伊等。此外,临床症状包括Pia类病变,通常已知其与细胞内劳索尼亚菌感染相关。

    PCV2 ORF2 immunogenic composition
    2.
    发明公开
    PCV2 ORF2 immunogenic composition 审中-公开
    PCV2ORF2免疫原性组合物

    公开(公告)号:EP2275130A2

    公开(公告)日:2011-01-19

    申请号:EP10174456.3

    申请日:2006-12-28

    IPC分类号: A61K39/12

    摘要: The present invention relates to an immunogenic composition that comprises a porcine circovirus type 2 (PCV2) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV2 infection. Preferably, they include lymphadenopathy, lymphoid depletion and/or multinucleated/giant histiocytes. Moreover, the clinical symptoms include lymphadenopathy in combination with one or a multiple of the following symptoms in pigs: (1) interstitial pneumonia with interlobular edema, (2) cutaneous pallor or icterus, (3) mottled atrophic livers, (4) gastric ulcers, (5) nephritis and (6) reproductive disorders, e.g. abortion, stillbirths, mummies, etc. Furthermore the clinical symptoms include Pia like lesions, normally known to be associated with Lawsonia intracellularis infections.

    摘要翻译: 本发明涉及包含用于治疗几种临床表现(疾病)的2型猪圆环病毒(PCV2)抗原的免疫原性组合物。 优选地,临床表现与PCV2感染有关。 优选地,它们包括淋巴结病,淋巴耗竭和/或多核/巨组织细胞。 此外,临床症状包括淋巴结病和猪中的一种或多种以下症状:(1)伴有小叶间水肿的间质性肺炎,(2)皮肤苍白或黄疸,(3)斑驳萎缩肝,(4)胃溃疡 ,(5)肾炎和(6)生殖障碍,例如 流产,死胎,木乃伊等。此外,临床症状包括Pia类病变,通常已知其与细胞内劳索尼亚菌感染相关。

    PCV2 ORF2 immunogenic composition
    9.
    发明公开
    PCV2 ORF2 immunogenic composition 审中-公开
    PCV2 ORF2 immunogenische Zusammensetzung

    公开(公告)号:EP2275130A3

    公开(公告)日:2011-03-23

    申请号:EP10174456.3

    申请日:2006-12-28

    IPC分类号: A61K39/12

    摘要: The present invention relates to an immunogenic composition that comprises a porcine circovirus type 2 (PCV2) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV2 infection. Preferably, they include lymphadenopathy, lymphoid depletion and/or multinucleated/giant histiocytes. Moreover, the clinical symptoms include lymphadenopathy in combination with one or a multiple of the following symptoms in pigs: (1) interstitial pneumonia with interlobular edema, (2) cutaneous pallor or icterus, (3) mottled atrophic livers, (4) gastric ulcers, (5) nephritis and (6) reproductive disorders, e.g. abortion, stillbirths, mummies, etc. Furthermore the clinical symptoms include Pia like lesions, normally known to be associated with Lawsonia intracellularis infections.

    摘要翻译: 本发明涉及包含用于治疗几种临床表现(疾病)的猪圆环病毒2型(PCV2)抗原的免疫原性组合物。 优选地,临床表现与PCV2感染相关。 优选地,它们包括淋巴结病,淋巴细胞减少和/或多核/巨细胞组织细胞。 此外,临床症状包括与猪中的一种或多种以下症状相结合的淋巴结病:(1)间质性肺炎与小叶间水肿,(2)皮肤苍白或黄疸,(3)斑驳萎缩性肝脏,(4)胃溃疡 ,(5)肾炎和(6)生殖障碍,例如 流产,死胎,木乃伊等。此外,临床症状包括Pia样病变,通常已知与细胞内劳森氏菌感染有关。